Antipodes Partners LTD Alcon Inc Transaction History
Antipodes Partners LTD
- $2.83 Billion
- Q3 2024
A detailed history of Antipodes Partners LTD transactions in Alcon Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 1,076,360 shares of ALC stock, worth $92.6 Million. This represents 3.81% of its overall portfolio holdings.
Number of Shares
1,076,360Holding current value
$92.6 Million% of portfolio
3.81%Shares
1 transactions
Others Institutions Holding ALC
# of Institutions
729Shares Held
242MCall Options Held
2.35MPut Options Held
1.65M-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.67 Billion0.04% of portfolio
-
Credit Suisse Ag Zurich, V815.5MShares$1.33 Billion1.27% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL12MShares$1.04 Billion0.32% of portfolio
-
Aristotle Capital Management, LLC Los Angeles, CA11.9MShares$1.02 Billion2.3% of portfolio
-
Harding Loevner LP Bridgewater, NJ9.27MShares$797 Million5.43% of portfolio
About ALCON INC
- Ticker ALC
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 490,087,008
- Market Cap $42.1B
- Description
- Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...